It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Two companies say their vaccines are 95% effective. What does that mean?

World / Science & Health Nov 21, 2020

Two companies say their vaccines are 95% effective. What does that mean?

by Carl Zimmer

You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that’s not how the math works.

10-year cancer survival rate in Japan rises to 58.3%

National Nov 21, 2020

10-year cancer survival rate in Japan rises to 58.3%

The survey has continually shown an improvement in life expectancy since the center started collecting data around 2000.

Hospitals in Japan's hard-hit areas stretched amid COVID-19 surge

National Nov 20, 2020

Hospitals in Japan's hard-hit areas stretched amid COVID-19 surge

by Ryusei Takahashi

There is concern that a rising trend in the number of severely ill patients could overwhelm hospitals, health care facilities and intensive care units, delaying critical care.

What COVID-19 is costing women?

Commentary / World Nov 20, 2020

What COVID-19 is costing women?

by Pinelopi Koujianou Goldberg

The pandemic has compounded a longstanding problem for women around the world: large and persistent barriers to participating in the economy and public life on an equal basis with men.

WHO advises doctors not to use Gilead’s remdesivir for COVID-19

World / Science & Health Nov 20, 2020

WHO advises doctors not to use Gilead’s remdesivir for COVID-19

The recommendation is a blow to Gilead’s drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.

COVID-19 mutated. Can vaccines keep up?

Commentary / World Nov 19, 2020

COVID-19 mutated. Can vaccines keep up?

by Faye Flam

So far, scientists have found only one mutation that improves the survival ability of the virus. The more transmissible strain is referred to as G614.

Can first vaccines bring herd immunity? Experts have doubts.

World / Science & Health Nov 19, 2020

Can first vaccines bring herd immunity? Experts have doubts.

by Ludwig Burger and Kate Kelland

Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.

Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'

World / Science & Health Nov 19, 2020

Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'

Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.

Can Japan bridge the vaccine divide?

Commentary / Japan Nov 18, 2020

Can Japan bridge the vaccine divide?

by Shihoko Goto

Japan too has been developing its own drug, Avigan, against COVID-19. Yet the drug being developed by Fujifilm is not a vaccine but rather a treatment for coronavirus symptoms.

China takes risk in rushing to use unproven coronavirus vaccines

Asia Pacific / Science & Health Nov 18, 2020

China takes risk in rushing to use unproven coronavirus vaccines

by Sui-lee Wee and Elsie Chen

China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.

Sinovac's COVID-19 vaccine induces quick immune response, study finds

Asia Pacific / Science & Health Nov 18, 2020

Sinovac's COVID-19 vaccine induces quick immune response, study finds

Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday. While the early to mid-stage trials were not designed to assess ...

Pfizer reaches safety milestone for COVID-19 vaccine, CEO says

World / Science & Health Nov 18, 2020

Pfizer reaches safety milestone for COVID-19 vaccine, CEO says

Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators. Speaking at a virtual conference hosted by The ...

« 1 … 8 9 10 … 122 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times